Wide QRS complex tachycardias: Are you bothered by irregularity? Authors: John M. Miller, Nektarios Vasilottos, Varun Vanka Published: 2026 While “irregularity” is a common problem in gastroenterology, it can sometimes cause difficulty for the cardiac electrophysiologist as well, in a very different context. For example, wide QRS complex tachycardias (WCTs) are usually rather regular, with cycle length [CL] variation on a standard ECG of <20 ms. When CL variation during tachycardia is so much that it is obvious on a standard ECG (roughly 50 ms change from longest to shortest RR interval), the vast majority of the time the diagnosis is atrial fibrillation (AF) with preexisting or rate-dependent bundle branch block (BBB). Less commonly, AF, flutter or irregular atrial tachycardia still activate the ventricles via the normal atrioventricular (AV) conduction system but result in a non-aberrant pattern due to the presence of markedly abnormal baseline QRS complexes (such as in patients with severe cardiomyopathy or repaired congenital heart disease). In a still smaller group, an erratic supraventricular rhythm is conducted over one or more AV accessory pathways to produce a preexcited tachycardia (PXT). The common feature of all of these irregular WCTs is the driving rhythm – AF or AT, and the usual reaction when evaluating such an ECG is to immediately exclude ventricular tachycardia (VT) from the list of possible diagnoses. The study by Saggu et al. [1] reminds us that not all irregular WCTs are due to a conducted supraventricular rhythm: some are in fact due to VT. This is not a common presentation; in their series of 615 cases of inflammatory cardiomyopathy, 177 had VT and in only 7 (4%) of these was the rhythm irregular (>50 ms RR interval variation). The authors found important common features in these 7 patients: though they had a pathologic diagnosis (inflammatory cardiomyopathy) in which ventricular scarring (the substrate for reentrant VT) can occur, all had fundamentally normal sinus rhythm ECGs and normal left ventricular (LV) function on echocardiogram. Thus, whatever scarring may have been present was of insufficient volume to cause a significant ECG or echocardiographic abnormality (magnetic resonance imaging was not used). They also observed that episodes of VT in these cases started and stopped spontaneously; they do not elaborate on this as to whether the initiating QRS complex was the same as those that followed in the episode (implying a focal mechanism) or if the initiating QRS complex differed from those in the sustained arrhythmia (implying reentry). They also do not give details on mapping and ablation features of these arrhythmias (in 4 cases), as the focus of the report was instead on making the correct ECG diagnosis. This series raises several questions as noted below. Why is VT sometimes irregular? VT is often slightly irregular at its onset but the differences in CL tend to decrease over the first minute of an episode; by the time a standard ECG is obtained, most episodes appear regular. Most VTs in patients without structural heart disease (SHD) are due to a focal process (automaticity or triggered activity), in which a focus discharges at a relatively fixed CL determined most likely by intracellular calcium dynamics. Focal discharges can be very erratic for unclear reasons, but likely again related to variations in cellular calcium dynamics; this results in a very irregular VT, that may persist at a relatively slow rate but may become incessant. VT in the presence of SHD is usually due to scar-based reentry with a relatively fixed path length and mean conduction velocity, yielding a relatively stable CL. When monomorphic VT is irregular in this setting, it is usually due to variations in conduction velocity during diastole (QRS complexes generally having constant duration). It has been suggested that long RR intervals during irregular VT allow more time for full recovery of excitability in some portions of the circuit, resulting in faster conduction of the wave front; this may subsequently encounter partially recovered tissue that slows propagation, and the cycle repeats. If the disparities in CL dampen, VT stabilizes and the rate regularizes; if CL changes are amplified from beat to beat, conduction may eventually fail entirely (a proposed mechanism for VT termination in non-sustained episodes). Persistence of significant variability of CL suggests an intrinsic resilience of the circuit; this can result in incessant VT and/or resistance to efforts to pace-terminate. Thus, both focal processes and reentry can present as irregular VT, and in each setting the basis of the irregularity can facilitate an incessant arrhythmia. What are the implications for VT mapping and ablation? Although as noted, detailed mapping and ablation features in Saggu et al.’s series were not given, it is reasonable to infer that these VTs had focal sources (normal LV function, no significant abnormalities on voltage mapping, spontaneous arrhythmia onset). In this type of arrhythmia, the ablation target site has minimal pre-QRS activation (20-50 ms) rather than mid-diastolic and entrainment cannot be used (although pace-matching of VT can be used). This has obvious importance for mapping and ablation strategies in a patient population (inflammatory cardiomyopathy) in whom macroreentry is usually operative. Ablation was performed in this series on patients with VT storm, a setting in which either focal or reentrant mechanisms may be present as indicated above. This underscores the critical importance for the operator to be as certain as possible about which mechanism is responsible for VT, since mapping characteristics differ so greatly. Finally, are there more specific ECG findings to distinguish VT from PXT in cases of irregular WCT? While most ECG algorithms to diagnose WCT suggest that a non-aberrant ECG pattern is either VT or (less likely) PXT, they do not further attempt to distinguish between the latter two. However, several publications have addressed this distinction. Steurer et al. [2] studied 149 VTs and 117 PXTs using 3 criteria (predominant negative QRS in V4-V6; QR complexes in any of V2 to V6; and non-1:1 AV relationship) and with all 3 positive, diagnosed VT with 75% sensitivity and 100% specificity. Jastrzebski et al. [3], studying 329 preexcited ECGs (PXT or atrial paced), used the VT score (tall R in V1; initial r in V1 or V2 > 40 ms; notched S in V1; initial R in aVR; lead II R wave peak time of ≥50 ms; lack of RS in any precordial lead [each of these = 1 point]; and AV dissociation [2 points]), showing that PXTs rarely had scores ≥3 and never ≥4, with good discrimination between VT and PXT. Vereckei et al. [4] evaluated 241 VTs and 59 PXTs using 4 steps (AV dissociation; initial R in aVR with R/S ratio >1; presence of QR complexes in any of V2-V4; predominant negative QRS in V4-V6) and found 73% sensitivity for VT; however, if none were present, PXT was diagnosed. Finally, Ni et al. [5] analyzed 137 VT and 68 PXT ECGs using 4 criteria (monophasic R in inferior leads and QS in aVR; predominant S waves in ≥2 of leads 1, aVF and V6; triphasic QRS or notching in V2; and Q or terminal notching in V5) and found the algorithm 93% sensitive for VT and, if all features were absent, PXT was diagnosed. When applied to the 7 ECGs in Saggu et al.’s series, the Vereckei algorithm diagnosed all as VT while the other 3 did almost as well (6/7 cases). The medical literature has many reports of irregular WCTs misdiagnosed as AF, with significant delays in delivery of correct therapy [6]. Reports such as Saggu et al.’s remind us to keep an open mind about diagnosis of irregular WCTs and apply different diagnostic tools as needed if there is any question. As it has been said,“Not all that’s irregular is atrial fib;Maybe next time around, I won’t be so glib!” “Not all that’s irregular is atrial fib; Maybe next time around, I won’t be so glib!” Declaration of competing interest Dr. Miller reports consulting and/or speaking honoraria arrangements with Abbott Electrophysiology; Biosense-Webster; Biotronik; Boston Scientific; Medtronic; and Vektor Medical, as well as fellow training support from Abbott Electrophysiology; Biosense-Webster; Boston Scientific; and Medtronic. Drs. Vasilottos and Vanka report no conflicts.